Skip to main content
Novartis
language-selector-globe United States | en
Choose Location
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe us
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • About 
      • Novartis in the US 
        • Diversity equity & inclusion  
        • Pay transparency-EPIC 
        • Our code of ethics 
      • Diversity, equity & inclusion  
        • Novartis US EEO / D&I report 2021 
        • Supplier diversity 
      • People and culture 
      • Products 
      • US Country Coordinating Committee 
      • External funding 
      • Contact us 
      Team meeting About
    • Patients and caregivers 
      • Novartis commitment to patients and caregivers 
      • Patient assistance 
      • Diseases 
        • Chronic spontaneous urticaria (CSU) 
        • Hidradenitis suppurativa (HS) 
        • Prostate Cancer (PC) 
        • Paroxysmal Nocturnal Hemoglobinuria (PNH) 
      • Participating in clinical trials 
      • Patient perspectives 
      • Adverse event reporting 
      • The STEP program 
        • Sickle cell disease (SCD) 
        • Program overview 
        • Multiple sclerosis (MS) 
        • Cancer 
        • Application for funding to help address health disparities 
        • Health disparities 
      • Patient resources 
      Patient smiling at doctor image Patients and caregivers
    • Healthcare professionals 
      • Novartis pipeline 
      • Novartis clinical trials 
      • Adverse event reporting 
      • HCP resources 
      • Personalized and Precision Medicine 
      • Health Information Technology Resources 
      Two doctors examining X-ray Healthcare professionals
    • ESG 
      • Ethical behavior 
        • Code of ethics 
        • SpeakUp 
        • PhRMA Code on interactions with healthcare professionals 
        • Business principles 
      • Ethics, risk and compliance 
        • Compliance program 
        • State laws 
        • Corporate integrity agreement 
        • Payments to HCPs & HCOs 
        • Drug Supply Chain Security Act Information 
      • Corporate responsibility 
        • Population health 
        • Novartis in society US reports 
        • Novartis US Foundation 
        • Environmental sustainability 
        • People and communities 
      • Beacon of hope 
        • Beacon of hope: Measurable solutions for health equity 
        • Paving the way for a brighter, more equitable future 
      Novartis East Hanover Campus Landscaping ESG
    • News 
      • News archive 
      • Statements 
      • Stories 
      • Contacts 
      Co-workers having a meeting News
    • Careers 
      • Career search 
      • Meet the teams 
      • Early career 
      • Personal growth 
      • How we work 
      • Employee benefits 
      • Diversity, equity & inclusion 
      • Awards & recognition 
      Meeting in Atrium Careers
    Grandmother, mother and daughter smiling and laughing on a beach Home
  1. Home
  2. Careers
  3. Career Search
  • Sort by Sort ascending
  • Job Title Sort ascending
  • Site
  • Location
  • Division
  • Business
  • Functional Area
  • Date Posted
Job Title Sort ascending Site Location Division Business Functional Area Date Posted
Allergy-Territory Account Specialist – Ann Arbor, MI – Remote Field Sales (USA) USA US Innovative Medicines Sales Sep 10, 2024
Allergy- Territory Account Specialist- Corpus Christi- Remote Field Sales (USA) USA US Innovative Medicines Sales Oct 23, 2024
Allergy- Territory Account Specialist – San Francisco, CA – Remote Field Sales (USA) USA US Innovative Medicines Sales Sep 27, 2024
Allergy- Territory Account Specialist – Detroit, MI – Remote Field Sales (USA) USA US Innovative Medicines Sales Sep 30, 2024
Allergy- Territory Account Specialist – Akron, OH– Remote Field Sales (USA) USA US Innovative Medicines Sales Sep 10, 2024
Allergy Territory Account Specialist- Fort Worth- Remote Field Sales (USA) USA US Innovative Medicines Sales Oct 22, 2024
Allergy Territory Account Specialist- Austin West- Remote Field Sales (USA) USA US Innovative Medicines Sales Oct 22, 2024
Allergy Territory Account Specialist- Austin East- Remote Field Sales (USA) USA US Innovative Medicines Sales Oct 22, 2024
Allergy Territory Account Specialist – Queens, NY – Remote Queens (New York) USA US Innovative Medicines Sales Oct 15, 2024
Allergy Territory Account Specialist – Pasadena, CA – Remote Field Sales (USA) USA US Innovative Medicines Sales Sep 08, 2024
Allergy Territory Account Specialist - Los Angeles, CA (East) - Remote Field Sales (USA) USA US Innovative Medicines Sales Sep 23, 2024
Allergy Territory Account Specialist - Chicago, IL (South) - Remote Field Sales (USA) USA US Innovative Medicines Sales Sep 11, 2024
Allergy Territory Account Specialist - Chicago, IL (North) - Remote Field Sales (USA) USA US Innovative Medicines Sales Sep 23, 2024
Agile Project Management Lead Head Office (Japan) (Pharmaceuticals) Japan International Innovative Medicines Technology Transformation Jul 01, 2024
Administrative Expert / Professional RDQ Hyderabad (Office) India Development Innovative Medicines Facilities & Administration Aug 22, 2024
Administrateur Outils et Canaux Digitaux H/F Paris Headquarter (Novartis Pharma S.A.S.) France International Innovative Medicines Technology Transformation Oct 25, 2024
Admin Specialist Prague Czech Republic Operations CTS Procurement Sep 06, 2024
AD, QA, Evaluations and Integrations Cambridge (USA) USA Biomedical Research Pharma Research Quality Oct 25, 2024
AD, Patient Support Center - Program Monitoring Arizona USA US Innovative Medicines Quality Oct 04, 2024
AD, Market Access TA Strategy- Breast & Women's Cancer East Hanover USA US Innovative Medicines Market Access Oct 16, 2024
AD, Case Manager Immunology East Hanover USA US Innovative Medicines Sales Oct 25, 2024
AD, Access & Reimbursement - Minneapolis - Remote Field Non-Sales (USA) USA US Innovative Medicines Market Access Oct 17, 2024
AD Product Manager, Drug Candidate Selection Software Applications Basel (City) Switzerland Biomedical Research Pharma Research Research & Development Sep 03, 2024
Access & Reimbursement Manager NPS - Enterprise - Rocky Mountains - Remote Field Non-Sales (USA) USA US Innovative Medicines Sales Oct 17, 2024
Access & Reimbursement Manager NPS - Enterprise - Great Lakes - Remote Field Non-Sales (USA) USA US Innovative Medicines Sales Oct 17, 2024
ABL - RLT Field Sales (USA) USA US Innovative Medicines Sales Apr 30, 2024
349145BR - Director, Channel Enablement and Optimization Governance East Hanover USA US Innovative Medicines Marketing Sep 13, 2024
(高级)大区经理 Shanghai (Shanghai) China International Innovative Medicines Sales Oct 17, 2024
(高级)大区经理 Chongqing (Chongqing Province) China International Innovative Medicines Sales Jul 19, 2024
(高级)大区经理 Zhengzhou (Henan Province) China International Innovative Medicines Sales Oct 18, 2024
(高级)地区经理 Bozhou (Anhui Province) China International Innovative Medicines Sales Sep 24, 2024
(高级)地区经理 Shanghai (Shanghai) China International Innovative Medicines Sales Jun 21, 2024
(高级)地区经理 Shanghai (Shanghai) China International Innovative Medicines Sales Jun 21, 2024
(高级)地区经理 Bozhou (Anhui Province) China International Innovative Medicines Sales Sep 24, 2024
(高级)地区经理 Shanghai (Shanghai) China International Innovative Medicines Sales Jun 21, 2024
(高级)地区经理 Shanghai (Shanghai) China International Innovative Medicines Sales Jun 21, 2024
(高级)地区经理 Shanghai (Shanghai) China International Innovative Medicines Sales Jun 21, 2024
(高级)地区经理 Bozhou (Anhui Province) China International Innovative Medicines Sales Sep 24, 2024
(高级)地区经理 Bozhou (Anhui Province) China International Innovative Medicines Sales Sep 24, 2024
(高级)地区经理 Bozhou (Anhui Province) China International Innovative Medicines Sales Sep 24, 2024
(高级)地区经理 Shanghai (Shanghai) China International Innovative Medicines Sales Jun 21, 2024
(高级)地区经理 Shanghai (Shanghai) China International Innovative Medicines Sales Jun 21, 2024
(高级)地区经理 Bozhou (Anhui Province) China International Innovative Medicines Sales Sep 24, 2024
(高级)地区经理 Bozhou (Anhui Province) China International Innovative Medicines Sales Sep 24, 2024
(高级)地区经理 Shanghai (Shanghai) China International Innovative Medicines Sales Jun 21, 2024
(高级)地区经理 Shanghai (Shanghai) China International Innovative Medicines Sales Jun 21, 2024
(高级)地区经理 Bozhou (Anhui Province) China International Innovative Medicines Sales Sep 24, 2024
(高级)地区经理 Bozhou (Anhui Province) China International Innovative Medicines Sales Sep 24, 2024
(高级)地区经理 Shanghai (Shanghai) China International Innovative Medicines Sales Jun 21, 2024
(高级)地区经理 Bozhou (Anhui Province) China International Innovative Medicines Sales Sep 24, 2024

Pagination

  • ‹ Previous page
  • 1
  • …
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • …
  • 42
  • › Next page

Novartis United States

Navigate Novartis
  • Patients & caregivers
  • Healthcare professionals
  • ESG
  • News
  • Careers
Media center
  • News archive
  • Statements
  • Stories
Our portfolio
  • Novartis clinical pipeline
  • Novartis product portfolio
Other Novartis US websites
  • Oncology HCP resources
  • Medical information
  • Global site
Footer Bottom
© 2024 Novartis Pharmaceuticals Corporation
  • Terms of use
  • Privacy policy
  • Consumer health privacy policy
  • Contacts
  • Site map
  • Web accessibility
Novartis Site Directory
This site is intended for US residents only